- Home
- TNXP vs LOGC Comparison
TNXP vs LOGC Comparison
Compare TNXP & LOGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- LOGC
- Stock Information
- Founded
- TNXP 2007
- LOGC 2010
- Country
- TNXP United States
- LOGC United States
- Employees
- TNXP N/A
- LOGC N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- LOGC Catalog/Specialty Distribution
- Sector
- TNXP Health Care
- LOGC Consumer Discretionary
- Exchange
- TNXP Nasdaq
- LOGC Nasdaq
- Market Cap
- TNXP 207.5M
- LOGC 185.5M
- IPO Year
- TNXP N/A
- LOGC 2020
- Fundamental
- Price
- TNXP $39.78
- LOGC $8.20
- Analyst Decision
- TNXP Strong Buy
- LOGC
- Analyst Count
- TNXP 2
- LOGC 0
- Target Price
- TNXP $585.00
- LOGC N/A
- AVG Volume (30 Days)
- TNXP 1.3M
- LOGC 265.6K
- Earning Date
- TNXP 05-12-2025
- LOGC 05-09-2025
- Dividend Yield
- TNXP N/A
- LOGC N/A
- EPS Growth
- TNXP N/A
- LOGC N/A
- EPS
- TNXP N/A
- LOGC N/A
- Revenue
- TNXP $10,041,000.00
- LOGC $7,000,000.00
- Revenue This Year
- TNXP $12.17
- LOGC $433.37
- Revenue Next Year
- TNXP $789.15
- LOGC N/A
- P/E Ratio
- TNXP N/A
- LOGC N/A
- Revenue Growth
- TNXP N/A
- LOGC N/A
- 52 Week Low
- TNXP $6.76
- LOGC $4.92
- 52 Week High
- TNXP $558.08
- LOGC $9.34
- Technical
- Relative Strength Index (RSI)
- TNXP 74.56
- LOGC 65.72
- Support Level
- TNXP $25.40
- LOGC $7.64
- Resistance Level
- TNXP $37.84
- LOGC $8.22
- Average True Range (ATR)
- TNXP 4.17
- LOGC 0.35
- MACD
- TNXP 1.75
- LOGC 0.05
- Stochastic Oscillator
- TNXP 87.00
- LOGC 98.25
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About LOGC ContextLogic Inc.
ContextLogic Inc is an online shopping store. The store provides personalized products, clothing products, accessories, gaming products and equipment, cosmetics, plastic products, mobile covers, and other products. Geographically, it derives majority of its revenue from Europe and also has a presence in North America; South America, and other countries.